These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 37525273)

  • 1. The cardio-renal-metabolic connection: a review of the evidence.
    Marassi M; Fadini GP
    Cardiovasc Diabetol; 2023 Jul; 22(1):195. PubMed ID: 37525273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan.
    Kadowaki T; Maegawa H; Watada H; Yabe D; Node K; Murohara T; Wada J
    Diabetes Obes Metab; 2022 Dec; 24(12):2283-2296. PubMed ID: 35929483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio-Renal-Metabolic Syndrome.
    Nichols GA; Amitay EL; Chatterjee S; Steubl D
    Metab Syndr Relat Disord; 2023 Jun; 21(5):261-266. PubMed ID: 37130317
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials.
    McCullough PA; Amin A; Pantalone KM; Ronco C
    J Am Heart Assoc; 2022 Jun; 11(11):e024139. PubMed ID: 35616212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifestyle factors and their relative contributions to longitudinal progression of cardio-renal-metabolic multimorbidity: a prospective cohort study.
    Zhang N; Liu X; Wang L; Zhang Y; Xiang Y; Cai J; Xu H; Xiao X; Zhao X
    Cardiovasc Diabetol; 2024 Jul; 23(1):265. PubMed ID: 39026309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease among US adults with type 2 diabetes and cardiovascular diseases: A national estimate of prevalence by KDIGO 2012 classification.
    Wang T; Xi Y; Lubwama R; Hannanchi H; Iglay K; Koro C
    Diabetes Metab Syndr; 2019; 13(1):612-615. PubMed ID: 30641775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Of heart and kidney: a complicated love story.
    Gaita D; Mihaescu A; Schiller A
    Eur J Prev Cardiol; 2014 Jul; 21(7):840-6. PubMed ID: 23012690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiometabolic and cardiorenal syndromes interactions in Algerian diabetic-hypertensive patient: interest of predictive multi-biomarkers strategy to renal dysfunction].
    Zoubiri H; Kacimi G; Haffaf el M; Oudjit B; Adjroud N; Koceir EA
    Ann Biol Clin (Paris); 2015; 73(4):443-53. PubMed ID: 26411911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Cardiorenal Syndrome to Chronic Cardiovascular and Kidney Disorder: A Conceptual Transition.
    Zoccali C; Mallamaci F; Halimi JM; Rossignol P; Sarafidis P; De Caterina R; Giugliano R; Zannad F
    Clin J Am Soc Nephrol; 2024 Jun; 19(6):813-820. PubMed ID: 37902772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults.
    Schechter M; Melzer Cohen C; Yanuv I; Rozenberg A; Chodick G; Bodegård J; Leiter LA; Verma S; Lambers Heerspink HJ; Karasik A; Mosenzon O
    Cardiovasc Diabetol; 2022 Jun; 21(1):104. PubMed ID: 35689214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.
    Cherney DZI; Repetto E; Wheeler DC; Arnold SV; MacLachlan S; Hunt PR; Chen H; Vora J; Kosiborod M
    Am J Nephrol; 2020; 51(1):74-82. PubMed ID: 31812955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
    Pugliese G; Solini A; Bonora E; Orsi E; Zerbini G; Fondelli C; Gruden G; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Penno G;
    Cardiovasc Diabetol; 2014 Mar; 13():59. PubMed ID: 24624891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Tumlin JA; Costanzo MR; Chawla LS; Herzog CA; Kellum JA; McCullough PA; Ronco C
    Contrib Nephrol; 2013; 182():158-73. PubMed ID: 23689661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardio-renal-metabolic syndrome: clinical features and dapagliflozin eligibility in a real-world heart failure cohort.
    Beles M; Masuy I; Verstreken S; Bartunek J; Dierckx R; Heggermont W; Oeste C; De Boeck M; Fovel I; Maris M; Vermeulen Z; Vanderheyden M
    ESC Heart Fail; 2023 Aug; 10(4):2269-2280. PubMed ID: 37095712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment.
    Granata A; Clementi A; Virzì GM; Brocca A; de Cal M; Scarfia VR; Zanoli L; Ronco C; Corrao S; Malatino L
    Eur J Intern Med; 2016 May; 30():1-6. PubMed ID: 26961461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
    Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
    Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and cardiovascular complications.
    Di Lullo L; House A; Gorini A; Santoboni A; Russo D; Ronco C
    Heart Fail Rev; 2015 May; 20(3):259-72. PubMed ID: 25344016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations.
    Shubrook JH; Neumiller JJ; Wright E
    Postgrad Med; 2022 May; 134(4):376-387. PubMed ID: 34817311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of four equations for estimation of glomerular filtration rate in predicting cardiovascular events and subclinical vascular disease in patients with type-2 diabetes.
    Sow MA; Magne J; Toure F; Teissier MP; Aboyans V
    Prim Care Diabetes; 2022 Feb; 16(1):196-201. PubMed ID: 34996689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
    Handelsman Y; Anderson JE; Bakris GL; Ballantyne CM; Beckman JA; Bhatt DL; Bloomgarden ZT; Bozkurt B; Budoff MJ; Butler J; Dagogo-Jack S; de Boer IH; DeFronzo RA; Eckel RH; Einhorn D; Fonseca VA; Green JB; Grunberger G; Guerin C; Inzucchi SE; Jellinger PS; Kosiborod MN; Kushner P; Lepor N; Mende CW; Michos ED; Plutzky J; Taub PR; Umpierrez GE; Vaduganathan M; Weir MR
    J Diabetes Complications; 2022 Feb; 36(2):108101. PubMed ID: 34922811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.